カテゴリ： MarketLine, 企業調査, 香港

Shangri-La Asia Ltd：戦略・SWOT・企業財務分析

◆英語タイトル：Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014613
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月14日
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：香港
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Shangri-La Asia Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Shangri-La Asia Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Shangri La Asia limited (SLIM) is an investment holding company that owns and operates hotels and associated properties across the world. The company offers hotel ownership, property rentals, hotel management services, and property sales. It also provides marketing, consultation, reservation, real estate development and operation activities (golf club), wine trading, and other related services. The company owns and leases office spaces, commercial properties, and serviced apartments, and residences. It operates under the name of Shangri-La, Kerry Hotel, Hotel Jen, Traders Hotel, Rasa, Summer Palace, Shang Palace, and CHI, The Spa at Shangri-La. The company operates across Asia, Oceania, Europe, Africa, and North America. Shangri La Asia limited is headquartered in Hong Kong.

Scope

- Detailed information on Shangri-La Asia Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Shangri-La Asia Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Shangri-La Asia Ltd including a breakdown and examination of key business segments
- Intelligence on Shangri-La Asia Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Shangri-La Asia Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Shangri-La Asia Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Shangri-La Asia Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Shangri-La Asia Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Shangri-La Asia Ltd: Company Overview
Shangri-La Asia Ltd: Overview and Key Facts
Shangri-La Asia Ltd: Overview
Shangri-La Asia Ltd: Key Facts
Shangri-La Asia Ltd: Key Employees
Shangri-La Asia Ltd: Key Employee Biographies
Shangri-La Asia Ltd: Major Products and Services
Shangri-La Asia Ltd: Company History
Shangri-La Asia Ltd: Management Statement
Shangri-La Asia Ltd: Locations and Subsidiaries
Shangri-La Asia Ltd: Key Competitors
Shangri-La Asia Ltd: Company Analysis
Shangri-La Asia Ltd: Business Description
Shangri-La Asia Ltd: SWOT Analysis
Shangri-La Asia Ltd: SWOT Overview
Shangri-La Asia Ltd: Strengths
Shangri-La Asia Ltd: Weaknesses
Shangri-La Asia Ltd: Opportunities
Shangri-La Asia Ltd: Threats
Shangri-La Asia Ltd: Corporate Financial Deals Activity
Shangri-La Asia Ltd: Financial Deals Overview
Shangri-La Asia Ltd: Targets and Partners
Shangri-La Asia Ltd: Top Deals 2013 – 2017YTD*
Shangri-La Asia Ltd: Partnership
Shangri-La Asia Ltd: Recent Developments
Shangri-La Asia Ltd: News and Events Summary
Shangri-La Asia Ltd: Business Expansion
Shangri-La Asia Ltd: Contracts
Shangri-La Asia Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Shangri-La Asia Ltd: Key Facts
Table 2: Shangri-La Asia Ltd: Key Employees
Table 3: Shangri-La Asia Ltd: Locations and Subsidiaries
Table 4: Shangri-La Asia Ltd: Key Competitors
Table 5: Shangri-La Asia Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Shangri-La Asia Ltd: Targets and Partners
Table 7: Shangri-La Asia Ltd: Top Deals 2013 - 2017YTD*
Table 8: Shangri-La Asia Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 9: Shangri-La Asia Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 10: Shangri-La Asia Ltd: News and Events Summary
Table 11: Shangri-La Asia Ltd: Business Expansion
Table 12: Shangri-La Asia Ltd: Contracts
Table 13: Shangri-La Asia Ltd: Strategy and Operations

★海外企業調査レポート[Shangri-La Asia Ltd：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Selecta Biosciences Inc (SELB)-製薬・医療分野：企業M&A・提携分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a clinical-stage biopharmaceutical company which develops immunotherapies and vaccines to prevent and treat disease. The company’s pipeline products include SEL-212, SELA-070, SEL-701, LMB-100 and others. Its synthetic vaccine particle (SVP) t …
  • Royal Dutch Shell Plc (RDSA)：石油・ガス：M&Aディール及び事業提携情報
    Summary Royal Dutch Shell Plc (Shell) is an integrated oil and gas company. The company explores for and produces oil and gas from conventional fields and sources such as tight rock, shale and coal formations. Its refining and petrochemical complexes across the world add value to its upstream produc …
  • Forty Seven Inc (FTSV)：製薬・医療：M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …
  • Otonomy Inc (OTIC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Otonomy Inc (Otonomy) develops and markets treatments for diseases and disorders of the ear. The company’s Otiprio is the US FDA approved ciprofloxacin otic suspension indicated during tympanostomy tube placement surgery in pediatric patients. Its pipeline portfolio encompasses Otividex for …
  • Ben E. Keith Co：企業の戦略的SWOT分析
    Ben E. Keith Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • China Power Clean Energy Development Co Ltd (0735)：企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (0735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Seegene Inc (096530)：企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Sinclair Pharma Plc (SPH)：医療機器：M&Aディール及び事業提携情報
    Summary Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collag …
  • Lam Research Corporation (LRCX)：企業の財務・戦略的SWOT分析
    Lam Research Corporation (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Shanghai Desano Pharmaceutical Co Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Shanghai Desano Pharmaceutical Co Ltd (Desano) is a drug manufacturing company that manufactures, develops, and markets generic APIs. The company’s products include generic APIs of anti-retroviral, oncology and anti-malarial products. It also provides APIs and FPPs. Desano's API manufacturin …
  • Aldi Einkauf GmbH & Co oHG：企業の戦略・SWOT・財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cleco Corporate Holdings, LLC：企業の戦略・SWOT・財務情報
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Magellan Midstream Partners LP (MMP)：企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Korea Aerospace Industries Ltd.：企業の戦略・SWOT・財務情報
    Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sokolovska uhelna, pravni nastupce, A.S.：企業の戦略的SWOT分析
    Sokolovska uhelna, pravni nastupce, A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Doosan Infracore Co Ltd (042670)：企業の財務・戦略的SWOT分析
    Doosan Infracore Co Ltd (042670) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • American Bio Medica Corp (ABMC)：企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Viesgo：電力：M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • Pfenex Inc (PFNX)-製薬・医療分野：企業M&A・提携分析
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • The Trendlines Group Ltd (42T)：製薬・医療：M&Aディール及び事業提携情報
    Summary The Trendlines Group Ltd (Trendlines) is a commercialization company that invents, discovers, invests, and incubates medical and agricultural technologies. The company offers business incubation, partner and channel development, market strategies, business plans, research and development and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆